Article

You have full text access to this OnlineOpen article

Misregulation of gene expression in the redox-sensitive NF-κb-dependent limb outgrowth pathway by thalidomide

  1. Jason M. Hansen1,
  2. Siew-Ging Gong2,
  3. Martin Philbert1,
  4. Craig Harris1,*

Article first published online: 5 SEP 2002

DOI: 10.1002/dvdy.10150

Issue

Developmental Dynamics

Developmental Dynamics

Volume 225, Issue 2, pages 186–194, October 2002

Additional Information

How to Cite

Hansen, J. M., Gong, S.-G., Philbert, M. and Harris, C. (2002), Misregulation of gene expression in the redox-sensitive NF-κb-dependent limb outgrowth pathway by thalidomide. Dev. Dyn., 225: 186–194. doi: 10.1002/dvdy.10150

Author Information

  1. 1

    Toxicology Program, Environmental Health Sciences, School of Public Health, University of Michigan, Ann Arbor, Michigan

  2. 2

    Orthodontic and Pediatric Dentistry, School of Dentistry, University of Michigan, Ann Arbor, Michigan

*Department of Environmental Health Sciences, SPH II M6116, 1420 Washington Heights, Ann Arbor, MI 48109-2029

Publication History

  1. Issue published online: 19 SEP 2002
  2. Article first published online: 5 SEP 2002
  3. Manuscript Accepted: 22 JUL 2002
  4. Manuscript Received: 26 NOV 2001

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (713K)

REFERENCES

  • Arlen RR, Wells PG. 1996. Inhibition of thalidomide teratogenicity by acetylsalicylic acid: evidence for prostaglandin H synthase-catalyzed bioactivation of thalidomide to a teratogenic reactive intermediate. J Pharmacol Exp Ther 277: 1649–1658.
  • Baldwin AS. 1996. The NF-kB and I-kB proteins. New discoveries and insights. Ann Rev Immunol 14: 649–681.
  • Beuerle PA, Henkle T. 1994. Function and activation of NF-kB in the immune system. Ann Rev Immunol 12: 141–179.
  • Bourgeois P, Bolcato-Bellemin A-L, Danse J-M, Bloch-Zupan A, Yoshiba K, Stoetzel C, Perrin-Schmitt F. 1998. The variable expressivity and incomplete penetrance of the twist-null heterozygous mouse phenotype resemble those of human Saethre-Chotzen syndrome. Hum Mol Genet 7: 954–957.
  • Bushdid PB, Brantley DM, Yull FE, Blaeuer GL, Hoffman LH, Niswander L, Kerr LD. 1998. Inhibition of NF-kB activity results in disruption of the apical ectodermal ridge and aberrant limb morphogenesis. Nature 392: 615–622.
  • Crossley PH, Minowada G, MacArthur CA, Martin GR. 1996. Roles for FGF8 in the induction, initiation, and maintenance of chick limb development. Cell 84: 127–136.
  • Fabro S. 1981. The teratogenicity of thalidomide. In: JuchauMR, editor. The biochemical basis of chemical teratogenesis. New York: Elsevier/North-Holland Press.
  • Flohe L, Brigelius-Flohe P, Saliou C, Traber MG, Packer L. 1997. Redox regulation of NF-kappa B activation. Free Radic Biol Med 22: 1115–1126.
  • Galter D, Mihm S, Droge W. 1994. Distinct effects of glutathione disulphide on the nuclear transcription factor kappa B and the activator protein-1. Eur J Biochem 221: 639–648.
    Direct Link:
  • Ginn-Pease ME, Whisler RL. 1998. Redox signals and NF-kB activation in T cells. Free Radic Biol Med 25: 346–361.
  • Hansen JM, Carney EW, Harris C. 1999. Thalidomide-induced alterations of glutathione status in organogenesis stage rat and rabbit conceptuses in vitro. Reprod Toxicol 13: 547–554.
  • Hansen JM, Choe H-S, Carney EW, Harris C. 2001a. Differential antioxidant enzyme activities and glutathione content between rat and rabbit conceptuses. Free Radic Biol Med 30: 1078–1088.
  • Hansen JM, Carney EW, Harris C. 2001b. Altered differentiation in rat and rabbit limb bud micromass cultures by glutathione modulating agents. Free Radic Biol Med 31: 1582–1592.
  • Hansen JM, Harris KK, Philbert MA, Harris C. 2002. Preferential depletion of glutathione and alteration of redox status in rabbit vs. rat limbs. J Pharmacol Exp Ther 300: 768–776.
  • Hayashi T, Ueno Y, Okamoto T. 1993. Oxidoreductive regulation of nuclear factor kappa B: involvement of a cellular reducing catalyst thioredoxin. J Biol Chem 268: 11380–11388.
  • Kanegae Y, Tavares AT, Belmonte YC, Verma IM. 1998. Role of Rel/NF-kB transcription factors during the outgrowth of the vertebrate limb. Nature 392: 611–614.
  • Kato S, Sekine K. 1999. FGF-FGFR signaling in vertebrate organogenesis. Cell Mol Biol 45: 631–638.
  • Kistler A, Howard BW. 1987. Testing of retinoids for teratogenicity in vitro: use of micromass limb bud cell culture. Methods Enzymol 190: 427–433.
  • Kraus P, Fraidenraich D, Loomis CA. 2001. Some distal limb structures develop in mice lacking Sonic hedgehog signaling. Mech Dev 100: 45–58.
  • Martin GR. 1998. The roles of FGFs in the early development of vertebrate limbs. Genes Dev 12: 1571–1586.
  • Matthews JR, Hay RT. 1995. Regulation of the DNA binding activity of NF-kB. Int J Biochem Cell Biol 27: 865–879.
  • Matthews JR, Wakasugi N, Virelizier JL, Yodoi J, Hay RT. 1992. Thioredoxin regulates the DNA binding activity of NF-κB by reduction of a disulphide bond involving cysteine 62. Nucleic Acids Res 20: 3821–3830.
  • Mitomo K, Nakayama K, Fujimoto K, Sun X, Seki S, Yamamoto K. 1994. Two different cellular redox systems regulate the DNA-binding activity of the p50 subunit of NF-κB in vitro. Gene 145: 197–203.
  • Ohuchi H, Nakagawa T, Yamamoto A, Araga A, Ohata T, Ishimaru Y, Yoshioka H, Kuwana T, Nohno T, Yamasaki M, Itoh N, Noji S. 1997. The mesenchymal factor, FGF10, initiates and maintains the outgrowth of the chick limb bud through interaction with FGF8, an apical ectodermal factor. Development 124: 2235–2244.
  • Parman T, Wiley JM, Wells PG. 1999. Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity. Nat Med 5: 582–585.
  • Paznekas WA, Cunningham ML, Howard TD, Korf BR, Lipson MH, Grix AW, Feingold M, Goldberg R, Borochowitz Z, Aleck K. 1998. Genetic heterogeneity of Saethre-Chotzen syndrome, due to TWIST and FGFR mutations. Am J Hum Genet 62: 1370–1380.
  • Philbert MA, Beiswanger CM, Waters DK, Reuhl KR, Lowndes HE. 1991. Cellular and regional distribution of reduced glutathione in the nervous system of the rat: histochemical localization by mercury orange and o-phthaldialdehyde-induced histofluorescence. Toxicol Appl Pharmacol 107: 215–227.
  • Rice DP, Åberg T, Chan Y-S, Tang Z, Kettunen PJ, Pakarinen L, Maxson RE, Thesleff I. 2000. Integration of FGF and TWIST in calvarial bone and suture development. Development 127: 1845–1855.
  • Sauer H, Gunther J, Heschler J, Wartenberg M. 2000. Thalidomide inhibits angiogenesis in embryoid bodies by the generation of hydroxyl radicals. Am J Pathol 156: 151–158.
  • Schardein JL. 1993. Chemically induced birth defects. New York: Marcel Dekker, Inc.
  • Schmahl H-J, Dencker L, Plum C, Chahoud I, Nau H. 1996. Stereoselective distribution of the teratogenic thalidomide analogue EM12 in the early embryo of marmoset monkey, Wistar rat and NMRI mouse. Arch Toxicol 70: 749–756.
  • Sen CK, Packer L. 1996. Antioxidant and redox regulation of gene transcription. FASEB J 10: 709–720.
  • Summerbell D. 1974. A quantitative analysis of the effect of excision of the AER from the chick limb-bud. J Embryol Exp Morphol 32: 651–660.
  • Sun Y, Oberley LW. 1996. Redox regulation of transcriptional activators. Free Radic Biol Med 21: 335–348.
  • Toledano M, Leonard WJ. 1991. Modulation of transcription factor NF-κB binding activity by oxidation-reduction in vitro. Proc Nat Acad Sci USA 88: 4328–4332.
  • Vogel A, Rodriguez C, Izpisúa-Belmonte J. 1996. Involvement of FGF-8 in initiation, outgrowth and patterning of the vertebrate limb. Development 122: 1737–1750.
  • Wilkinson DG. 1992. Whole mount in situ hybridization of vertebrate embryos. In: In situ hybridization. Oxford: Oxford University Press. 75 p.
  • Xu X, Weinstein M, Li C, Naski M, Cohen RI, Ornitz, DM, Leder P, Deng C. 1998. Fibroblast growth factor receptor 2 (FGFR2)-mediated reciprocal regulation loop between FGF8 and FGF10 is essential for limb induction. Development 125: 753–765.
View Full Article (HTML) Get PDF (713K)